European Pharmaceutical Review

NOVEMBER 8, 2022

Pharmaceutical manufacturers have submitted Citizen Petitions raising safety or efficacy concerns about proposed competing generic and biosimilar products, and such submissions often delay FDA approval of the proposed products while the FDA resolves the pending petitions.

Food and Drug Administration 52

Food and Drug Administration Pharma Prescription Manufacturing 52

pharmaphorum

OCTOBER 26, 2022

When people think about pharma, they often think about “big” pharma: large, faceless corporations. The status isn’t awarded lightly and Chiesi is the largest pharmaceutical manufacturer to be named a B Corp. “We But rare diseases are a particularly important and challenging focus area. Chiesi’s philosophy in action.

Patients 75

Patients Pharma Consulting Transportation 75

Pharmaceutical Technology

SEPTEMBER 13, 2022

This approach will support its manufacturer partners throughout the pharmaceutical development and marketing processes. An international team of scientific, regulatory, and safety and compliance (GxP) specialists, PharmaLex is based in Germany.

Biopharma 52

Biopharma Manufacturing Pharmaceutical manufacturing Consulting 52

European Pharmaceutical Review

OCTOBER 12, 2023

September 2023 saw a wave of new pharmaceutical manufacturing facility expansions and launches across Europe. Research by the Confederation of British Industry (CBI) , released in September this year, highlighted progress for UK manufacturing in its latest Industrial Trends Survey. Kerry, Ireland.

Pharmaceutical manufacturing 80

Pharmaceutical manufacturing Manufacturing Pharmaceutical Pharma 80

Pharmaceutical Technology

SEPTEMBER 15, 2022

Packaging plays a vital role in maintaining the quality, safety, user-friendliness and marketability of drugs and other pharmaceutical products. The download contains detailed information on commercial pharmaceutical packaging contractors, and their product and service lines, alongside contact details to aid your hiring decision.

Leads 52

Leads Marketing Pharmaceutical Pharmaceutical manufacturing 52

PM360

DECEMBER 20, 2023

Given China’s status as the world’s second most populous nation and an economic powerhouse, it represents both a monumental market opportunity and a dynamic arena of challenges for pharmaceutical products. In 2021, the out-of-pocket (OOP) cost accounts for 28% of the whole healthcare expenses compared to 15.4% billion people in 2023).

Marketing 105

Marketing Insurance Medical Manufacturing 105

Clarivate

MARCH 14, 2024

Nitrosamines have garnered significant attention from the pharmaceutical industry due to their detection in commonly prescribed medications for conditions like type 2 diabetes, high blood pressure, and heartburn. [1] Manufacturers, healthcare providers, and consumers alike face the need to quickly adapt.

Pharmaceutical 52

Pharmaceutical Manufacturing Food Healthcare Provider 52

PM360

AUGUST 9, 2022

One reason for this growth is an increasing demand for personalized healthcare technologies as patients look for advances in how healthcare is delivered following the pandemic. Pharma Manufacturer Solutions. GM of Manufacturer Solutions. Furthermore, it is estimated to reach $6.5 billion in 2030 at a CAGR of 9.2%.

Prescription 105

Prescription Medical Side effects Patients 105

Contrarian Sales Techniques

FEBRUARY 26, 2023

It is noteworthy that Malaysia has a pharmaceutical manufacturing sector that almost exclusively produces generic drugs, with sales revenues amounting to only 1.5% of gross domestic product (GDP). I also note that the five largest companies typically sell originator drugs and account for 47 percent of total drug imports.

Pharmaceutical 52

Pharmaceutical Medicine Government Side effects 52

Pharmaceutical Technology

AUGUST 30, 2022

International companies investing in the emerging market of Brazilian pharmaceutical manufacturing will see a higher return on investment than from developed market equivalents, if they choose to compete with local manufacturers to supply Brazil’s growing market and the greater South American region.

Manufacturing 78

Manufacturing Marketing Pharma Distribution 78

European Pharmaceutical Review

JULY 25, 2022

Consequently, pharmaceutical manufacturers risk their reputation if impersonating products fail to deliver the expected quality or health impact. Essentially, both counterfeit and falsified medicines pose risks to public health and threaten to undermine the healthcare system and pharmaceutical industry.

Pharmaceutical 79

Pharmaceutical Medicine Pharmaceutical manufacturing Manufacturing 79

World of DTC Marketing

DECEMBER 10, 2020

However, because of manufacturer discounts and rebates, the extent to which increases in wholesale list prices are associated with amounts paid by patients and insurers is poorly characterized. Pharma companies continue to be among the most profitable industries, even outperforming tech companies. The Pharma Spin.

Insurance 181

Insurance Pharma Manufacturing Retail 181